Aldeyra Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Aldeyra Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $47.36 million for the year ending 2018.

  • Aldeyra Therapeutics, Inc. showed an increase of +136.5% in Cash And Cash Equivalents At Carrying Value from 2017 to 2018.
  • This data is from Aldeyra Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 8, 2019.
  • XBRL data for this metric is available from 2012 to 2018 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2012 to 2018), Aldeyra Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 3,770.2%.
  • Historical annual values: Fiscal year 2018: $47.36 million | Fiscal year 2017: $20.02 million | Fiscal year 2016: $12.02 million | Fiscal year 2015: $14.65 million | Fiscal year 2014: $8.53 million | Fiscal year 2013: $3.26 million | Fiscal year 2012: $1.22 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: